Cite
Rosanortriterpenes A–B, Two Promising Agents from Rosa laevigata var. leiocapus, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models.
MLA
Li, Bai-Lin, et al. “Rosanortriterpenes A–B, Two Promising Agents from Rosa Laevigata Var. Leiocapus, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models.” Evidence-Based Complementary & Alternative Medicine (ECAM), Nov. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1155/2020/8872945.
APA
Li, B.-L., Hu, J.-J., Xie, J.-D., Ni, C., Liang, H.-J., Li, Q.-R., Yuan, J., & Wu, J.-W. (2020). Rosanortriterpenes A–B, Two Promising Agents from Rosa laevigata var. leiocapus, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models. Evidence-Based Complementary & Alternative Medicine (ECAM), 1–9. https://doi.org/10.1155/2020/8872945
Chicago
Li, Bai-Lin, Juan-Juan Hu, Jin-Dan Xie, Chen Ni, Hui-Jun Liang, Qian-Ran Li, Jie Yuan, and Jie-Wei Wu. 2020. “Rosanortriterpenes A–B, Two Promising Agents from Rosa Laevigata Var. Leiocapus, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models.” Evidence-Based Complementary & Alternative Medicine (ECAM), November, 1–9. doi:10.1155/2020/8872945.